Antigen Targeting Consulting

ATCS Inc is a privately held, pre-revenue biotechnology firm combining a service-based CRO business with an internal therapeutic discovery engine. Its core expertise lies in protein-level antigen analysis, antibody humanization, biosimilar development, and cell-based assay services, primarily serving the research and preclinical markets. The company's long-term vision is to leverage its service-derived insights and a fusion of modern and traditional medicine approaches to build a proprietary pipeline of therapeutic candidates, though no disclosed programs have reached clinical stages. Its operational footprint spans San Diego, CA, and Worcester, MA.

Integrated platform for antigen analysis, antibody humanization, and cell-based assay development, combined with a discovery engine that screens and validates compounds from oriental traditional medicine using modern immunology techniques.

In CRO services, ATCS competes with large global players (LabCorp, IQVIA) and numerous niche biotechnology service providers. In therapeutic discovery, it faces all biopharma companies pursuing immunology targets, and its traditional medicine approach competes with academic groups and a handful of biotechs focused on natural product drug discovery.